Psychobiologic correlates of treatment response in schizophrenia

✍ Scribed by Jeffrey A. Lieberman; Jose Ma Alvir; Amy Koreen; Steven Geisler; Miranda Chakos; Brian Sheitman; Margaret Woerner

• Book ID: 103925995
• Publisher: Nature Publishing Group
• Year: 1996
• Tongue: English
• Weight: 641 KB
• Volume: 14
• Category: Article
• ISSN: 1470-634X
• DOI: 10.1016/0893-133x(95)00200-w

✦ Synopsis

In studies conducted on largely treatment naive patients in their first episode of psychosis, we have found that treatment outcome is quite good and that most patients recover or at least achieve a substantial degree of symptom remission. However, over the course of their illness and in the context of subsequent psychotic episodes, they may experience some decrease in their treatment response from illness progression. In addition, the heterogeneity of treatment outcome is associated with specific clinical (gender, primary negative symptoms of the deficit state, duration of psychosis) and biological variables (pHVA, ventricular volume). It is unclear whether these variables represent aspects of discrete subtypes of schizophrenia or dimensional measures of pathology within the broad context of a unitary disease entity.